Monday, June 26
07:30 AM – 08:00 AM
09:10 AM – 09:50 AM
Health EquityMulti-Stakeholder Panel: Explore a New Era of Value-Based Pricing Agreements, Models, and Innovations in 2023 and Beyond
<ul style="margin-bottom:0in;" type="disc"> <li style='margin:0in;font-size:15px;font-family:"Calibri",sans-serif;color:#333333;background:white;'><span style='font-size:14px;font-family:"Open Sans",sans-serif;'>Evaluate the hinderances and successes of value-based models to date and key lessons learned</span></li> <li style='margin:0in;font-size:15px;font-family:"Calibri",sans-serif;color:#333333;background:white;'><span style='font-size:14px;font-family:"Open Sans",sans-serif;'>Examine risk-sharing and outcomes-based contracts and value-based arrangements</span></li> <li style='margin:0in;font-size:15px;font-family:"Calibri",sans-serif;color:#333333;background:white;'><span style='font-size:14px;font-family:"Open Sans",sans-serif;'>Explore opportunities for cross-stakeholder partnerships to advance value-based care and industry alignment</span></li> <li style='margin:0in;font-size:15px;font-family:"Calibri",sans-serif;color:#333333;background:white;'><span style='font-size:14px;font-family:"Open Sans",sans-serif;'>Discuss the common challenges and opportunities for improvement to achieve value-based goals</span></li> </ul>
12:00 PM – 01:10 PM
02:30 PM – 03:25 PM
KeynoteMorning Plenary – Recent Developments at the Patent Trial and Appeal Board (PTAB)
Jesus Zayas
– Vice President Technology
– The Healthcare Innovation Company
Jane Doe
– VP Business Development
– The Hunter Group
This is another test session Updates on efforts to improve the process for challenging issued patents before the Patent Trial and Appeal Board 2022 Case Review and Trends Legislation considered in Congress and their impact on IP and Patents in 2023